379 related articles for article (PubMed ID: 31292250)
21. Structure and immunogenicity of pre-fusion-stabilized human metapneumovirus F glycoprotein.
Battles MB; Más V; Olmedillas E; Cano O; Vázquez M; Rodríguez L; Melero JA; McLellan JS
Nat Commun; 2017 Nov; 8(1):1528. PubMed ID: 29142300
[TBL] [Abstract][Full Text] [Related]
22. Generation of recombinant metapneumovirus nucleocapsid protein as nucleocapsid-like particles and development of virus-specific monoclonal antibodies.
Petraitytė-Burneikienė R; Nalivaiko K; Lasickienė R; Firantienė R; Emužytė R; Sasnauskas K; Zvirblienė A
Virus Res; 2011 Nov; 161(2):131-9. PubMed ID: 21827798
[TBL] [Abstract][Full Text] [Related]
23. Human metapneumovirus virus-like particles induce protective B and T cell responses in a mouse model.
Cox RG; Erickson JJ; Hastings AK; Becker JC; Johnson M; Craven RE; Tollefson SJ; Boyd KL; Williams JV
J Virol; 2014 Jun; 88(11):6368-79. PubMed ID: 24672031
[TBL] [Abstract][Full Text] [Related]
24. The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness.
Skiadopoulos MH; Biacchesi S; Buchholz UJ; Riggs JM; Surman SR; Amaro-Carambot E; McAuliffe JM; Elkins WR; St Claire M; Collins PL; Murphy BR
J Virol; 2004 Jul; 78(13):6927-37. PubMed ID: 15194769
[TBL] [Abstract][Full Text] [Related]
25. Characterization of Epitope-Specific Anti-Respiratory Syncytial Virus (Anti-RSV) Antibody Responses after Natural Infection and after Vaccination with Formalin-Inactivated RSV.
Widjaja I; Wicht O; Luytjes W; Leenhouts K; Rottier PJM; van Kuppeveld FJM; Haijema BJ; de Haan CAM
J Virol; 2016 Jul; 90(13):5965-5977. PubMed ID: 27099320
[TBL] [Abstract][Full Text] [Related]
26. The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein.
Smith SA; de Alwis AR; Kose N; Harris E; Ibarra KD; Kahle KM; Pfaff JM; Xiang X; Doranz BJ; de Silva AM; Austin SK; Sukupolvi-Petty S; Diamond MS; Crowe JE
mBio; 2013 Nov; 4(6):e00873-13. PubMed ID: 24255124
[TBL] [Abstract][Full Text] [Related]
27. Design and Evaluation of a Multi-Epitope Peptide of Human Metapneumovirus.
Li X; Guo L; Kong M; Su X; Yang D; Zou M; Liu Y; Lu L
Intervirology; 2015; 58(6):403-12. PubMed ID: 27096202
[TBL] [Abstract][Full Text] [Related]
28. VLPs generated by the fusion of RSV-F or hMPV-F glycoprotein to HIV-Gag show improved immunogenicity and neutralizing response in mice.
Trinité B; Durr E; Pons-Grífols A; O'Donnell G; Aguilar-Gurrieri C; Rodriguez S; Urrea V; Tarrés F; Mane J; Ortiz R; Rovirosa C; Carrillo J; Clotet B; Zhang L; Blanco J
Vaccine; 2024 May; 42(15):3474-3485. PubMed ID: 38641492
[TBL] [Abstract][Full Text] [Related]
29. Human Metapneumovirus.
Schuster JE; Williams JV
Microbiol Spectr; 2014 Oct; 2(5):. PubMed ID: 26104361
[TBL] [Abstract][Full Text] [Related]
30. A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo.
Williams JV; Chen Z; Cseke G; Wright DW; Keefer CJ; Tollefson SJ; Hessell A; Podsiad A; Shepherd BE; Sanna PP; Burton DR; Crowe JE; Williamson RA
J Virol; 2007 Aug; 81(15):8315-24. PubMed ID: 17522220
[TBL] [Abstract][Full Text] [Related]
31. Production and characterization of neutralizing monoclonal antibodies against human metapneumovirus F protein.
Ma X; Endo R; Ebihara T; Ishiguro N; Ishiko H; Kikuta H
Hybridoma (Larchmt); 2005 Aug; 24(4):201-5. PubMed ID: 16120026
[TBL] [Abstract][Full Text] [Related]
32. Antibody Epitopes of Pneumovirus Fusion Proteins.
Huang J; Diaz D; Mousa JJ
Front Immunol; 2019; 10():2778. PubMed ID: 31849961
[TBL] [Abstract][Full Text] [Related]
33. Potent Human Single-Domain Antibodies Specific for a Novel Prefusion Epitope of Respiratory Syncytial Virus F Glycoprotein.
Xun G; Song X; Hu J; Zhang H; Liu L; Zhang Z; Gong R
J Virol; 2021 Aug; 95(18):e0048521. PubMed ID: 34160257
[TBL] [Abstract][Full Text] [Related]
34. Respiratory syncytial virus fusion nanoparticle vaccine immune responses target multiple neutralizing epitopes that contribute to protection against wild-type and palivizumab-resistant mutant virus challenge.
Gilbert BE; Patel N; Lu H; Liu Y; Guebre-Xabier M; Piedra PA; Glenn G; Ellingsworth L; Smith G
Vaccine; 2018 Dec; 36(52):8069-8078. PubMed ID: 30389195
[TBL] [Abstract][Full Text] [Related]
35. Structure of the human metapneumovirus fusion protein with neutralizing antibody identifies a pneumovirus antigenic site.
Wen X; Krause JC; Leser GP; Cox RG; Lamb RA; Williams JV; Crowe JE; Jardetzky TS
Nat Struct Mol Biol; 2012 Mar; 19(4):461-3. PubMed ID: 22388735
[TBL] [Abstract][Full Text] [Related]
36. Structural characterization of M8C10, a neutralizing antibody targeting a highly conserved prefusion-specific epitope on the metapneumovirus fusion trimerization interface.
Xiao X; Wen Z; Chen Q; Shipman JM; Kostas J; Reid JC; Warren C; Tang A; Luo B; O'Donnell G; Fridman A; Chen Z; Vora KA; Zhang L; Su H-P; Eddins MJ
J Virol; 2023 Dec; 97(12):e0105223. PubMed ID: 38032197
[TBL] [Abstract][Full Text] [Related]
37. A Sendai virus recombinant vaccine expressing a gene for truncated human metapneumovirus (hMPV) fusion protein protects cotton rats from hMPV challenge.
Russell CJ; Jones BG; Sealy RE; Surman SL; Mason JN; Hayden RT; Tripp RA; Takimoto T; Hurwitz JL
Virology; 2017 Sep; 509():60-66. PubMed ID: 28605636
[TBL] [Abstract][Full Text] [Related]
38. Serological cross-reactivity of members of the Metapneumovirus genus.
Alvarez R; Jones LP; Seal BS; Kapczynski DR; Tripp RA
Virus Res; 2004 Sep; 105(1):67-73. PubMed ID: 15325082
[TBL] [Abstract][Full Text] [Related]
39. [Development and properties of neutralizing monoclonal antibodies for fusion protein of respiratory syncytial virus.].
Kushch AA; Klimova RR; Fedorova NE; Masalova OV; Niconova AA; Lesnova EI; Momotyuk ED; Demidova NA; Samartseva TG; Zverev VV
Vopr Virusol; 2019; 64(2):90-96. PubMed ID: 31412175
[TBL] [Abstract][Full Text] [Related]
40. Antigenic Site-Specific Competitive Antibody Responses to the Fusion Protein of Respiratory Syncytial Virus Were Associated With Viral Clearance in Hematopoietic Cell Transplantation Adults.
Ye X; Iwuchukwu OP; Avadhanula V; Aideyan LO; McBride TJ; Ferlic-Stark LL; Patel KD; Piedra FA; Shah DP; Chemaly RF; Piedra PA
Front Immunol; 2019; 10():706. PubMed ID: 30984206
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
